Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of E7070 in metastatic breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• E7070

Snippet

Sponsor: Eisai Inc. | Conditions: Breast Neoplasms, Metastases | Phase 2 | Status: COMPLETED